Mature T/NK-cell lymphoproliferative disease and Epstein-Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate

Virchows Archiv

Volumn 462, Issue 4, 2013, Pages 399-407

  Kondo, Seiji ^a   Tanimoto, Kazuki ^a   Yamada, Kozue ^b   Yoshimoto, Goichi ^a   Suematsu, Eiichi ^a   Fujisaki, Tomoaki ^c   Oshiro, Yumi ^c   Tamura, Kazuo ^b   Takeshita, Morishige ^b   Okamura, Seiichi ^a  

^a NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c MATSUYAMA RED CROSS HOSPITAL   (Japan)

Author keywords

Epstein Barr virus; Methotrexate; Rheumatoid arthritis; T NK cell lymphoproliferative disorder

Indexed keywords

CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; DOXORUBICIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER STAGING; CELL MATURATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS INFECTION; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPANESE; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NK T CELL LYMPHOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; TREATMENT DURATION;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPHOPROLIFERATIVE DISORDERS; MALE; METHOTREXATE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84876470728     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-013-1389-1     Document Type: Article

References (30)

1. Wolfe F, Michaud K (2007) Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthritis Rheum 56:2886-2895 (Pubitemid 47502734)
2. Wong AK, Kerkoutian S, Said J, Rashidi H, Pullarkat ST (2011) Risk of lymphoma in patients receiving antitumor necrosis factor therapy: a meta-analysis of published randomized controlled studies. Clin Rheumatol 31:631-636
3. Yamada T, Nakajima A, Inoue E et al (2011) Incidence of malignancy in Japanese patients with rheumatoid arthritis. Rheumatol Int 31:1487-1492
4. Kamel OW, van de Rijn M, Weiss LM et al (1993) Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328:1317-1321 (Pubitemid 23131374)
5. Salloum E, Cooper DL, Howe G et al (1996) Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 14:1943-1949 (Pubitemid 26185470)
6. Rizzi R, Curci P, Delia M et al (2009) Spontaneous remission of «methotrexate-associated lymphoproliferative disorders» after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature. Med Oncol 26:1-9
7. Harris NL, Swerdlow S (2001) Methotrexate-associatred lymphoprolieferative disorders. In: Jaffe ES, Harris NL, Stein H, Vardiman J (eds) Pathology and genetics, tumors of haematopoietic and lymphoid tissues, World Health Organization classification of tumors. IARC Press, Lyon, pp 270-271
8. Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM (2002) Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum 46:3151-3158 (Pubitemid 35453523)
9. Gaulard P, Swerdlow SH, Harris NL, Jaffe ES, Sundstrom C (2008) Other iatrogenic immunodeficiency-associatred lymphoprolieferative disorders. In: Swerdlow SH, Campo E, Harris NL et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC press, Lyon, pp 350-351
10. Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J (2002) Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 99:3909-3915 (Pubitemid 35332027)
11. Lunemann JD, Frey O, Eidner T et al (2008) Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis. J Immunol 181:991-1000
12. Shah A, Diehl LF, St Clair EW (2009) T cell large granular lymphocyte leukemia associated with rheumatoid arthritis and neutropenia. Clin Immunol 132:145-152
13. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324 (Pubitemid 18091653)
14. Howe JG, Steitz JA (1986) Localization of Epstein-Barr virus small RNAs by in situ hybridization. Proc Natl Acad Sci U S A 83:9006-9010 (Pubitemid 17223525)
15. Gibson SE, Swerdlow SH, Craig FE et al (2011) EBV-postive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder? Am J Surg Pathol 35:807-815
16. Fox CP, Shannon-Lowe C, Rowe M (2011) Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations. Herpesviridae. doi: 10.1186/2042-4280-2-8
17. McKelvey EM, Gottlieb JA, Wilson HE et al (1976) Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer 38:1484-1493
18. Bonadonna G, Zucali R, Monfardini S, De Lena M, Uslenghi C (1975) Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer 36:252-259
19. Kojima M, Itoh H, Hirabayashi K et al (2006) Methotrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese cases. Pathol Res Pract 202:679-685
20. Nemoto Y, Taniguchi A, Kamioka M et al (2010) Epstein-Barr virus-infected subcutaneous panniculitis-like T-cell lymphoma associated with methotrexate treatment. Int J Hematol 92:364-368
21. Hatanaka K, Nakamura N, Kojima M et al (2010) Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma. Pathol Res Pract 206:9-13
22. Hatachi S, Kunitomi A, Aozasa K, Yagita M (2010) CD8(+) T-cell lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis during methotrexate therapy. Mod Rheumatol 20:500-505
23. Parker SR, Solomon AR, Lane JE (2008) A report of Epstein-Barr virus-positive primary cutaneous natural killer-/T-cell lymphoma. J Am Acad Dermatol 59:157-161
24. Kono H, Inokuma S, Matsuzaki Y et al (1999) Two cases of methotrexate induced lymphomas in rheumatoid arthritis: an association with increased serum IgE. J Rheumatol 26:2249-2253 (Pubitemid 29487026)
25. Prochorec-Sobieszek M, Rymkiewicz G, Makuch-Lasica H et al (2008) Characteristics of T-cell large granular lymphocyte proliferations associated with neutropenia and inflammatory arthropathy. Arthritis Res Ther. doi: 10.1186/ar2424 (Pubitemid 351837419)
26. Menke DM, Griesser H, Moder KG et al (2000) Lymphomas in patients with connective tissue disease. Comparison of p53 protein expression and latent EBV infection in patients immunosuppressed and not immunosuppressed with methotrexate. Am J Clin Pathol 113:212-218 (Pubitemid 30212552)
27. Feng WH, Cohen JI, Fischer S et al (2004) Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst 96:1691-1702 (Pubitemid 39585638)
28. Le Goff P, Chicault P, Saraux A, Baron D, Valls-Bellec I, Leroy JP (1998) Lymphoma with regression after methotrexate withdrawal in a patient with rheumatoid arthritis. Role for the Epstein-Barr virus. Rev Rhum Engl Ed 65:283-286 (Pubitemid 28198253)
29. Niitsu N, Okamoto M, Nakamine H, Hirano M (2010) Clinicopathologic correlations of diffuse large B-cell lymphoma in rheumatoid arthritis patients treated with methotrexate. Cancer Sci 101:1309-1313
30. Shaffer DR, Rooney CM, Gottschalk S (2010) Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation. Immunotherapy 2:663-671